These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17326326)

  • 21. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
    Calvo C; Hermida RC; Ayala DE; Ruilope LM
    J Hypertens; 2004 Apr; 22(4):837-46. PubMed ID: 15126927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database.
    Parati G; Schumacher H; Bilo G; Mancia G
    J Hypertens; 2010 Nov; 28(11):2177-83. PubMed ID: 20811294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.
    Zheng Z; Lin S; Shi H
    J Clin Hypertens (Greenwich); 2010 Jun; 12(6):414-21. PubMed ID: 20591086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of telmisartan vs. ramipril on 'dipping' status and blood pressure variability: pooled analysis of the PRISMA studies.
    Gosse P; Schumacher H
    Hypertens Res; 2014 Feb; 37(2):151-7. PubMed ID: 24048485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.
    White WB; Murwin D; Chrysant SG; Koval SE; Davidai G; Guthrie R
    Blood Press Monit; 2008 Feb; 13(1):21-7. PubMed ID: 18199920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
    Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
    Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telmisartan plus HCTZ vs. amlodipine plus HCTZ in older patients with systolic hypertension: results from a large ambulatory blood pressure monitoring study.
    Neldam S; Edwards C;
    Am J Geriatr Cardiol; 2006; 15(3):151-60. PubMed ID: 16687967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial cardiometabolic actions of telmisartan plus amlodipine therapy in elderly patients with poorly controlled hypertension.
    Bekki H; Yamamoto K; Sone M; Homma T; Nakata M; Nohara M; Fukami K; Okuda S; Yamagishi S
    Clin Cardiol; 2011 Apr; 34(4):261-5. PubMed ID: 21432858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension.
    Mallion J; Siche J; Lacourcière Y
    J Hum Hypertens; 1999 Oct; 13(10):657-64. PubMed ID: 10516734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension.
    White WB; Lacourciere Y
    J Hypertens; 2004 Oct; 22(10):2035-6; author reply 2036-8. PubMed ID: 15361777
    [No Abstract]   [Full Text] [Related]  

  • 34. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial.
    White WB; Weber MA; Davidai G; Neutel JM; Bakris GL; Giles T
    Blood Press Monit; 2005 Jun; 10(3):157-63. PubMed ID: 15923818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S; Ozkan G; Konca C; Kaynar K
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of switching from telmisartan, valsartan, olmesartan, or losartan to candesartan on morning hypertension.
    Hasegawa H; Takano H; Kameda Y; Kubota A; Kobayashi Y; Komuro I
    Clin Exp Hypertens; 2012; 34(2):86-91. PubMed ID: 22251314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET).
    Mancia G; Parati G; Bilo G; Gao P; Fagard R; Redon J; Czuriga I; Polák M; Ribeiro JM; Sanchez R; Trimarco B; Verdecchia P; van Mieghem W; Teo K; Sleight P; Yusuf S
    Hypertension; 2012 Dec; 60(6):1400-6. PubMed ID: 23071122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diurnal blood pressure control in the optimal treatment of hypertension].
    Alföldi S
    Orv Hetil; 2003 May; 144(18 Suppl 1):895-7. PubMed ID: 12785233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.
    White WB; Davidai G; Schumacher H
    J Hum Hypertens; 2009 Dec; 23(12):817-25. PubMed ID: 19357698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.